They have been especially used for cancer therapeutics by targeting surface receptors of tumor cells such as HER2 (22), CAIX (23), TAG-72 (24), DR5 (25), c-Met (26), EGFR (27), mesothelin (28), AgSK1 (29) and CD33 (30). This evidence concerns the gene ERBB2 and neoplasm.